TABLE 1.
Endpoint and antifungal | MIC (μg/ml)a
|
|||
---|---|---|---|---|
Range | 50% | 90% | Mean | |
50% inhibition | ||||
Ciclopirox | 0.06-2.0 | 1.0 | 1.0 | 0.96 |
Fluconazole | 0.125-≥64 | 1.0 | 8.0 | 4.09 |
Griseofulvin | 0.125-64 | 0.125 | 0.5 | 0.86 |
Itraconazole | 0.001-0.125 | 0.008 | 0.06 | 0.02 |
Posaconazole | 0.015-0.125 | 0.015 | 0.03 | 0.03 |
Terbinafine | 0.001-≥0.5 | 0.008 | 0.03 | 0.05 |
Voriconazole | 0.001-0.25 | 0.008 | 0.06 | 0.02 |
80% inhibition | ||||
Ciclopirox | 0.06-2.0 | 1.0 | 1.0 | 1.0 |
Fluconazole | 0.125-≥64 | 2.0 | 16.0 | 6.99 |
Griseofulvin | 0.125-≥64 | 0.125 | 0.5 | 0.93 |
Itraconazole | 0.001-0.5 | 0.015 | 0.125 | 0.04 |
Posaconazole | 0.015-0.25 | 0.015 | 0.06 | 0.04 |
Terbinafine | 0.001-≥0.5 | 0.008 | 0.03 | 0.06 |
Voriconazole | 0.001-≥0.5 | 0.015 | 0.06 | 0.03 |
50% and 90%, MIC50 and MIC90, respectively.